Phase 2 Dose-Ranging Study of SKY0402 for Prolonged Postoperative Analgesia in Subject Undergoing Hemorrhoidectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

July 31, 2008

Conditions
Postoperative Pain
Interventions
DRUG

SKY0402

SKY0402

DRUG

Bupivacaine HCl

Bupivacaine HCl

Trial Locations (7)

4600

JSC Imereti Regional Clinical Hospital of the Name A. Dzotsenidze, Kutaisi

33136

University of Miami/Jackson Memorial, Miami

77054

The Women's Hospital of Texas, Houston

92673

Accurate Clinical Trials, Inc., San Clemente

98405

Multicare Health Systems Laboratories, Tacoma

0159

JSC K. Eristavi National Center of Experimental and Clinical Surgery, Tbilisi

0160

Socieety with limited responsibility Proctology Center, Tbilisi

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY

NCT00529126 - Phase 2 Dose-Ranging Study of SKY0402 for Prolonged Postoperative Analgesia in Subject Undergoing Hemorrhoidectomy | Biotech Hunter | Biotech Hunter